Cargando…
Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease—Activated Receptor-2, in Human Corneal Epithelial Cells
Cathepsin S (CTSS) activity is increased in tears of Sjögren’s syndrome (SS) patients. This elevated CTSS may contribute to ocular surface inflammation. Human corneal epithelial cells (HCE-T cells) were treated with recombinant human CTSS at activity comparable to that in SS patient tears for 2, 4,...
Autores principales: | Klinngam, Wannita, Fu, Runzhong, Janga, Srikanth R., Edman, Maria C., Hamm-Alvarez, Sarah F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274678/ https://www.ncbi.nlm.nih.gov/pubmed/30423938 http://dx.doi.org/10.3390/ijms19113530 |
Ejemplares similares
-
Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren’s syndrome murine model
por: Fu, Runzhong, et al.
Publicado: (2020) -
Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren’s Syndrome
por: Meng, Zhen, et al.
Publicado: (2017) -
Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome
por: Klinngam, Wannita, et al.
Publicado: (2019) -
Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells
por: Fu, Runzhong, et al.
Publicado: (2021) -
Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome
por: Shah, Mihir, et al.
Publicado: (2017)